经皮冠状动脉介入治疗的长期预后：原发性冠状动脉疾病进展的意义。
Long-term outcome of percutaneous coronary intervention: the significance of native coronary artery disease progression.
机构信息
Cardiology Department, Patras University Hospital, Patras, Greece.
出版信息
Clin Cardiol. 2011 Oct;34(10):588-92. doi: 10.1002/clc.20929. Epub 2011 Sep 19.
Abstract
The extensive use of stents during percutaneous coronary intervention (PCI) is associated with concerns about their potential adverse effects. In-stent restenosis and stent thrombosis definitely significantly affect the PCI outcome. However, review of recent relevant studies suggests that stent-related problems may have been somewhat overestimated when compared to coronary artery disease (CAD) progression at nonstented coronary segments as causative factors of adverse cardiac clinical events late (>30 days) post-PCI. Both stent-related problems and native CAD progression have to be equally addressed to optimize the PCI clinical benefit.
摘要
经皮冠状动脉介入治疗 (PCI) 中广泛使用支架引起了对其潜在不良影响的关注。支架内再狭窄和支架内血栓形成肯定会显著影响 PCI 的结果。然而，最近相关研究的综述表明，与非支架置入冠状动脉节段的冠状动脉疾病 (CAD) 进展相比，支架相关问题可能被高估为 PCI 后晚期 (>30 天) 不良心脏临床事件的原因。为了优化 PCI 的临床获益，必须同等解决支架相关问题和原发性 CAD 进展。
相似文献
1
Long-term outcome of percutaneous coronary intervention: the significance of native coronary artery disease progression.
Clin Cardiol. 2011 Oct;34(10):588-92. doi: 10.1002/clc.20929. Epub 2011 Sep 19.
2
Intravascular ultrasound-guided percutaneous coronary interventions in contemporary practice.
Arch Cardiovasc Dis. 2009 Feb;102(2):143-51. doi: 10.1016/j.acvd.2008.11.002. Epub 2009 Feb 7.
3
Engineering a bioresorbable stent: REVA programme update.
EuroIntervention. 2009 Dec 15;5 Suppl F:F54-7. doi: 10.4244/EIJV5IFA9.
4
A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
EuroIntervention. 2011 May;7 Suppl K:K93-9. doi: 10.4244/EIJV7SKA16.
5
Coating bioabsorption and chronic bare metal scaffolding versus fully bioabsorbable stent.
EuroIntervention. 2009 Dec 15;5 Suppl F:F36-42. doi: 10.4244/EIJV5IFA6.
6
Drug-eluting stents: safe but not sufficient.
JACC Cardiovasc Interv. 2009 Jun;2(6):513-4. doi: 10.1016/j.jcin.2009.04.002.
7
Late-term clinical outcomes with zotarolimus- and sirolimus-eluting stents. 5-year follow-up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions).
JACC Cardiovasc Interv. 2011 May;4(5):543-50. doi: 10.1016/j.jcin.2010.12.014.
8
2-year results of the AUTAX (Austrian Multivessel TAXUS-Stent) registry beyond the SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) study.
JACC Cardiovasc Interv. 2009 Aug;2(8):718-27. doi: 10.1016/j.jcin.2009.05.019.
9
Nevo stent: a successful stent makeover.
Catheter Cardiovasc Interv. 2011 Jan 1;77(1):52-3. doi: 10.1002/ccd.22921.
10
Absorb Bioresorbable Scaffold Versus Xience Metallic Stent for Prevention of Restenosis Following Percutaneous Coronary Intervention in Patients at High Risk of Restenosis: Rationale and Design of the COMPARE ABSORB Trial.
Cardiovasc Revasc Med. 2019 Jul;20(7):577-582. doi: 10.1016/j.carrev.2019.04.013. Epub 2019 Apr 16.
引用本文的文献
1
Predictors of Stent Restenosis in Han and Uygur Patients with Coronary Heart Disease after PCI in the Xinjiang Region.
Cardiol Res Pract. 2022 Jul 31;2022:7845108. doi: 10.1155/2022/7845108. eCollection 2022.
2
A SNP involved in alternative splicing of is associated with clopidogrel resistance in coronary heart disease in Chinese population.
Aging (Albany NY). 2020 Nov 20;12(24):25684-25699. doi: 10.18632/aging.104177.
3
The effect of the debulking by excimer laser coronary angioplasty on long-term outcome compared with drug-coating balloon: insights from optical frequency domain imaging analysis.
Lasers Med Sci. 2020 Mar;35(2):403-412. doi: 10.1007/s10103-019-02833-1. Epub 2019 Jul 1.
4
Intra-Arterial Drug and Light Delivery for Photodynamic Therapy Using Visudyne®: Implication for Atherosclerotic Plaque Treatment.
Front Physiol. 2016 Sep 12;7:400. doi: 10.3389/fphys.2016.00400. eCollection 2016.
5
Treatment of in-stent restenosis with excimer laser coronary angioplasty: benefits over scoring balloon angioplasty alone.
Lasers Med Sci. 2016 Nov;31(8):1691-1696. doi: 10.1007/s10103-016-2039-z. Epub 2016 Aug 11.
6
The evolution and investigation of native coronary arteries in patients after coronary stent implantation: a study by 320-detector CT angiography.
Int J Cardiovasc Imaging. 2014 Jun;30 Suppl 1:13-24. doi: 10.1007/s10554-014-0417-9. Epub 2014 Apr 9.
本文引用的文献
1
A prospective natural-history study of coronary atherosclerosis.
N Engl J Med. 2011 Jan 20;364(3):226-35. doi: 10.1056/NEJMoa1002358.
2
Clinical predictors of plaque progression despite very low levels of low-density lipoprotein cholesterol.
J Am Coll Cardiol. 2010 Jun 15;55(24):2736-42. doi: 10.1016/j.jacc.2010.01.050.
3
Progression of coronary artery disease during long-term follow-up of the Swiss Interventional Study on Silent Ischemia Type II (SWISSI II).
Clin Cardiol. 2010 May;33(5):289-95. doi: 10.1002/clc.20775.
4
Intensive multifactorial intervention for stable coronary artery disease: optimal medical therapy in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) trial.
J Am Coll Cardiol. 2010 Mar 30;55(13):1348-58. doi: 10.1016/j.jacc.2009.10.062.
5
Mechanisms of nonfatal acute myocardial infarction late after stent implantation: the relative impact of disease progression, stent restenosis, and stent thrombosis.
Am Heart J. 2010 Mar;159(3):439-45. doi: 10.1016/j.ahj.2009.12.011.
6
Feasibility of noninvasive assessment of thin-cap fibroatheroma by multidetector computed tomography.
JACC Cardiovasc Imaging. 2009 Dec;2(12):1412-9. doi: 10.1016/j.jcmg.2009.09.012.
7
Stent thrombosis in Sweden: a report from the Swedish Coronary Angiography and Angioplasty Registry.
Circ Cardiovasc Interv. 2009 Oct;2(5):401-8. doi: 10.1161/CIRCINTERVENTIONS.108.844985. Epub 2009 Sep 8.
8
Effect of intensive statin therapy on clinical outcomes among patients undergoing percutaneous coronary intervention for acute coronary syndrome. PCI-PROVE IT: A PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) Substudy.
J Am Coll Cardiol. 2009 Dec 8;54(24):2290-5. doi: 10.1016/j.jacc.2009.09.010.
9
Effects of statin treatments on coronary plaques assessed by volumetric virtual histology intravascular ultrasound analysis.
JACC Cardiovasc Interv. 2009 Jul;2(7):679-88. doi: 10.1016/j.jcin.2009.03.015.
10
C-reactive protein predicts long-term mortality independently of low-density lipoprotein cholesterol in patients undergoing percutaneous coronary intervention.
Am Heart J. 2009 Aug;158(2):277-83. doi: 10.1016/j.ahj.2009.05.026.
Zotero 插件